|
Re: Standard of Care in BETonMACE
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 10:26AM
|
|
Re: Bioasis Announces Publication of Independent Research by MedImmune Validating xB3 Platform Technology
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 30, 2018 07:16PM
|
|
Clinical Trials
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 02, 2017 11:10AM
|
|
Question for BDAZ or BKC
|
2
|
Resverlogix Corp.
|
Jun 02, 2018 12:11PM
|
|
Re: Share price performance in context
|
2
|
Resverlogix Corp.
|
Nov 18, 2016 04:45PM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 07, 2018 08:57PM
|
|
Re: I don't see the logic behind selling shares and buying warrants.....
|
2
|
Resverlogix Corp.
|
Jul 20, 2017 04:25PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 23, 2022 04:22PM
|
|
Re: Can we infer perhaps that BETonMACE is properly powered from the FDA news?
|
2
|
Resverlogix Corp.
|
Jun 17, 2018 11:10PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
2
|
Resverlogix Corp.
|
Apr 13, 2018 12:17PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
2
|
Resverlogix Corp.
|
Apr 13, 2018 12:51PM
|
|
Re: The 34.4 million
|
2
|
Zenith Epigenetics
|
Dec 06, 2015 02:00PM
|
|
Re: Recap / webcast / blackout...
|
2
|
Resverlogix Corp.
|
Feb 29, 2016 01:13PM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
2
|
Resverlogix Corp.
|
Nov 17, 2016 07:17PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 17, 2018 12:26PM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
2
|
Resverlogix Corp.
|
Jun 06, 2017 10:15AM
|
|
Financing May 12-17
|
2
|
Resverlogix Corp.
|
Jun 12, 2021 02:16PM
|
|
Re: RVX PP
|
2
|
Resverlogix Corp.
|
Mar 17, 2020 10:54AM
|
|
Re: iceberg or ice cube?
|
2
|
Resverlogix Corp.
|
May 17, 2017 12:21PM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 23, 2021 03:27PM
|
